IL137564A0 - Recombinant proteins derived from hgf and msp - Google Patents

Recombinant proteins derived from hgf and msp

Info

Publication number
IL137564A0
IL137564A0 IL13756499A IL13756499A IL137564A0 IL 137564 A0 IL137564 A0 IL 137564A0 IL 13756499 A IL13756499 A IL 13756499A IL 13756499 A IL13756499 A IL 13756499A IL 137564 A0 IL137564 A0 IL 137564A0
Authority
IL
Israel
Prior art keywords
recombinant proteins
msp
hgf
proteins derived
deriving
Prior art date
Application number
IL13756499A
Other languages
English (en)
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of IL137564A0 publication Critical patent/IL137564A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL13756499A 1998-01-30 1999-01-27 Recombinant proteins derived from hgf and msp IL137564A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000179A ITMI980179A1 (it) 1998-01-30 1998-01-30 Proteine ricombinanti derivate da hgf e msp
PCT/EP1999/000478 WO1999038967A2 (en) 1998-01-30 1999-01-27 Recombinant proteins derived from hgf and msp

Publications (1)

Publication Number Publication Date
IL137564A0 true IL137564A0 (en) 2001-07-24

Family

ID=11378771

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13756499A IL137564A0 (en) 1998-01-30 1999-01-27 Recombinant proteins derived from hgf and msp
IL137564A IL137564A (en) 1998-01-30 2000-07-27 Recombinant proteins derived from HGF or MSP, their uses and processes for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL137564A IL137564A (en) 1998-01-30 2000-07-27 Recombinant proteins derived from HGF or MSP, their uses and processes for their preparation

Country Status (14)

Country Link
US (1) US6551991B1 (xx)
EP (1) EP1049778B1 (xx)
JP (1) JP4478329B2 (xx)
AT (1) ATE335080T1 (xx)
AU (1) AU740490B2 (xx)
CA (1) CA2319211C (xx)
DE (1) DE69932592T2 (xx)
ES (1) ES2270581T3 (xx)
HU (1) HU226717B1 (xx)
IL (2) IL137564A0 (xx)
IT (1) ITMI980179A1 (xx)
NZ (1) NZ506005A (xx)
WO (1) WO1999038967A2 (xx)
ZA (1) ZA99723B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2499896A1 (en) * 2002-10-07 2004-04-22 Genentech, Inc. Hepatocyte growth factor variants
CA2528157A1 (en) * 2003-06-06 2004-12-16 Kringle Pharma Inc. Cell-containing preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1993023541A1 (en) 1992-05-18 1993-11-25 Genentech, Inc. Hepatocyte growth factor variants
EP0642585B1 (en) * 1992-05-18 2005-12-28 Genentech, Inc. Activation of oligomerizing receptors by using fused receptor ligands
CA2144081C (en) * 1992-09-16 2004-11-30 Filip Roos Protection against liver damage by hgf

Also Published As

Publication number Publication date
EP1049778A2 (en) 2000-11-08
US6551991B1 (en) 2003-04-22
HU226717B1 (en) 2009-07-28
JP2002501745A (ja) 2002-01-22
CA2319211C (en) 2010-10-26
ITMI980179A1 (it) 1999-07-30
WO1999038967A3 (en) 1999-09-16
JP4478329B2 (ja) 2010-06-09
HUP0104598A1 (hu) 2002-03-28
NZ506005A (en) 2003-06-30
EP1049778B1 (en) 2006-08-02
DE69932592D1 (de) 2006-09-14
ZA99723B (en) 1999-07-29
CA2319211A1 (en) 1999-08-05
ES2270581T3 (es) 2007-04-01
WO1999038967A2 (en) 1999-08-05
DE69932592T2 (de) 2007-08-09
AU740490B2 (en) 2001-11-08
HUP0104598A3 (en) 2003-09-29
IL137564A (en) 2007-06-17
AU2424599A (en) 1999-08-16
ATE335080T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
BR9407956A (pt) Composiçao farmacêutica vetor de express o de adenovirus recombinante e kit par reduzir a proliferaçao de células tumorais
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
ATE276764T1 (de) Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
MX9800945A (es) Uso de griseofulvina para inhibir el crecimiento de canceres.
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
BR9808221A (pt) Método de tratamento de tumor.
ES2114073T3 (es) Regeneracion del higado inducida por morfogenes.
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE253117T1 (de) Adenovirus e4 proteine für induktion von zelltod
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
EP0214017A3 (en) Use of n,n,-dimethylbiguanid p-chorophenoxyacetate in the treatment of neuropathies and nerval degeneration
MX9606559A (es) Terapia para el cancer usando linfotoxina.
IL137564A0 (en) Recombinant proteins derived from hgf and msp
DE69815840D1 (de) Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren
ATE232398T1 (de) Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid
DE69814691T2 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ATE78164T1 (de) Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie.
UA88272C2 (ru) Применение полипептидов семейства купредоксина в лечении рака
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed